HeidiLSmithMDPhD

Infectious Disease • Silver Spring, MD

Medical Officer, FDA

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

Office
FDA-CDER
10903 New Hampshire Avenue
Silver Spring, MD 20993

Education & Training

UMass Chan Medical SchoolFellowship, Infectious Disease, 2006 - 2009
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2002 - 2006
Uconn School Of MedicineClass of 2002

Certifications & Licensure

MD State Medical License 2018 - 2025
MA State Medical License 2007 - 2022
NH State Medical License 2005 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

1 citations
Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults.
Heidi L Smith, Timothy J Bensman, Shrimant Mishra, Xianbin Li, Cheryl A Dixon
The Journal of Infectious Diseases. 2024-08-16
Reply to White et al.
Eliford Kitabi, Timothy J Bensman, Justin C Earp, Dakshina M Chilukuri, Heidi Smith
Clinical Infectious Diseases. 2022-08-25
3 citations
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: FDA Basis for Dose Determination of Artesunate for Injection in Pediatric Patients with Se...
Eliford Kitabi, Timothy J Bensman, Justin C. Earp, Dakshina Chilukuri, Heidi Smith
Clinical Infectious Diseases. 2021-09-07

Press Mentions

New Diphtheria Treatment Faces Financial Challenges05:25December 21st, 2017
William Campbell Loves Worms. And They Won Him a Nobel PrizeDecember 10th, 2015